{"id":57402,"date":"2024-02-27T17:40:48","date_gmt":"2024-02-27T17:40:48","guid":{"rendered":"https:\/\/medsname.com\/glisen-pm\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"glisen-pm","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/glisen-pm\/","title":{"rendered":"Glisen PM"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Glisen PM?<\/h3>\n<p style=\"margin:0;\"><strong>Glisen PM<\/strong> er en <strong>triple-drug fixed-dose combination<\/strong> av <strong>glimepiride, pioglitazone and metformin<\/strong> (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg) used for <strong>type 2 diabetes<\/strong> not controlled on dual therapy. It targets hyperglycaemia through three complementary mechanisms: glimepiride stimulates insulin release from the pancreas, pioglitazone reduces insulin resistance in muscle\/fat\/liver, and metformin reduces liver glucose output. Typical HbA1c reduction: <strong>2.0&ndash;2.5 points<\/strong>. Usual dose: one tablet once daily with breakfast. Side-effect profile combines hypoglycaemia risk (from glimepiride), weight gain and oedema (from pioglitazone), and metformin GI upset. Avoid in heart failure, active bladder cancer, eGFR &lt; 30, severe hepatic impairment, and sulfa allergy. This is typically a step before insulin initiation.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hva du f\u00e5r med MedsBase:<\/strong> WHO-GMP-sertifisert produsent \u00b7 Diskret emballasje \u00b7 Verdensomspennende levering \u00b7 1 400+ verifiserte <a href=\"https:\/\/medsbase.com\/nb\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er dekket av v\u00e5r <a href=\"https:\/\/medsbase.com\/nb\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Glisen PM?<\/h2>\n<p>Glisen PM is an oral fixed-dose combination tablet containing three active antidiabetic ingredients: <strong>glimepiride, pioglitazone and metformin hydrochloride<\/strong> (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg). It is manufactured by WHO-GMP certified manufacturer and supplied in packs of 30, 60, 90 or 180 tablets.<\/p>\n<p>Triple therapy in a single tablet is used when dual therapy (usually metformin + sulfonylurea or metformin + TZD) is not achieving glycaemic targets, and the clinician wants to intensify treatment without starting insulin yet.<\/p>\n<h2 class=\"wp-block-heading\">How Does Glisen PM Work?<\/h2>\n<p>The three components attack hyperglycaemia from three different directions:<\/p>\n<ul>\n<li><strong>Metformin<\/strong> &mdash; reduces hepatic glucose production; improves peripheral insulin sensitivity; no hypoglycaemia on its own.<\/li>\n<li><strong>Pioglitazon<\/strong> &mdash; PPAR-&gamma; agonist; improves insulin sensitivity in muscle, fat and liver; improves lipid profile and fatty liver; no hypoglycaemia on its own.<\/li>\n<li><strong>Glimepiride<\/strong> &mdash; third-generation sulfonylurea; closes beta-cell K<sub>ATP<\/sub> channels to <em>stimulate insulin release<\/em>. This is the component that adds hypoglycaemia risk.<\/li>\n<\/ul>\n<p>Combined HbA1c reduction is typically <strong>2.0&ndash;2.5 percentage points<\/strong> compared with dual therapy.<\/p>\n<h2 class=\"wp-block-heading\">Dosering og administrering<\/h2>\n<p><strong>Vanlig dose:<\/strong> one tablet once daily, with or just before breakfast. Some prescribers use one tablet twice daily with larger meals if HbA1c is not controlled on once-daily dosing.<\/p>\n<ul>\n<li><strong>Ta med mat<\/strong> &mdash; improves tolerability and times the sulfonylurea&rsquo;s insulin release to the post-meal glucose rise.<\/li>\n<li><strong>Do not skip meals<\/strong> &mdash; glimepiride can cause hypoglycaemia on an empty stomach.<\/li>\n<li><strong>Carry fast-acting carbohydrate<\/strong>.<\/li>\n<li>Monitor blood glucose, HbA1c, weight, ankle oedema, ALT, and renal function.<\/li>\n<li>Vitamin B12 check annually (long-term metformin).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Bivirkninger<\/h2>\n<p><strong>Vanlig:<\/strong><\/p>\n<ul>\n<li><strong>Hypoglykemi<\/strong> &mdash; from the glimepiride component; shakiness, sweating, palpitations, hunger, confusion. Treat with 15&nbsp;g fast-acting carbohydrate.<\/li>\n<li><strong>Vekt\u00f8kning<\/strong> &mdash; 2&ndash;4 kg on average (pioglitazone + glimepiride drive gain; metformin slightly offsets).<\/li>\n<li><strong>Perifert \u00f8dem<\/strong> &mdash; from pioglitazone; most common reason for stopping.<\/li>\n<li>Metformin GI side effects in first 1&ndash;2 weeks (diarrhoea, nausea, metallic taste).<\/li>\n<li>Mild anaemia (haemodilution from pioglitazone).<\/li>\n<\/ul>\n<p><strong>Sjeldent, men alvorlig:<\/strong> severe hypoglycaemia (especially in older adults, renal impairment); heart failure decompensation; bladder cancer (long-term high-dose pioglitazone); macular oedema; bone fracture in women; lactic acidosis (very rare; acute kidney injury or hypoxia).<\/p>\n<h2 class=\"wp-block-heading\">Legemiddelinteraksjoner<\/h2>\n<ul>\n<li>Many drugs raise hypoglycaemia risk: insulin, other antidiabetics, alcohol, trimethoprim\/sulfamethoxazole, fluconazole, clarithromycin, ACE inhibitors, high-dose salicylates, non-selective beta-blockers (also mask symptoms).<\/li>\n<li>Corticosteroids, thiazides, thyroid hormones, phenytoin, rifampicin, atypical antipsychotics, oral contraceptives reduce glucose-lowering effect.<\/li>\n<li><strong>Gemfibrozil<\/strong> &mdash; doubles pioglitazone levels; pioglitazone component limited to 15&nbsp;mg\/day.<\/li>\n<li><strong>IV contrast<\/strong> &mdash; hold Glisen PM pre- and post-procedure if eGFR &lt; 60.<\/li>\n<li><strong>Kationiske legemidler<\/strong> &mdash; raise metformin levels.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Who Should Not Take Glisen PM?<\/h2>\n<ul>\n<li>Hjertefeil (NYHA III\u2013IV)<\/li>\n<li>Active bladder cancer or unexplained haematuria<\/li>\n<li>Alvorlig nyresvikt (eGFR &lt; 30)<\/li>\n<li>Severe hepatic impairment; ALT &gt; 2.5&times; ULN<\/li>\n<li>Diabetisk ketoacidose; type 1 diabetes<\/li>\n<li>Overf\u00f8lsomhet mot sulfonamider (sulfa)<\/li>\n<li>Akutt sykdom med risiko for vevshypoksi<\/li>\n<li>Graviditet, amming<\/li>\n<li>Kjent overf\u00f8lsomhet mot noe av innholdsstoffene<\/li>\n<\/ul>\n<p><strong>In older adults (&gt; 65):<\/strong> triple therapy containing a sulfonylurea carries a high hypoglycaemia risk. Many clinicians prefer a DPP-4 inhibitor or SGLT-2 inhibitor instead of glimepiride in this group.<\/p>\n<h2 class=\"wp-block-heading\">Oppbevaring<\/h2>\n<p>Store Glisen PM below 30&deg;C in a dry place. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Vanlige sp\u00f8rsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">When is a triple-drug diabetes tablet like Glisen PM prescribed?<\/h3>\n<p>Usually when dual therapy (typically metformin + sulfonylurea, or metformin + TZD) is not achieving HbA1c targets, and the clinician wants to intensify oral therapy before starting insulin. It is also convenient for patients already taking these three medicines separately &mdash; one tablet instead of three improves adherence.<\/p>\n<h3 class=\"wp-block-heading\">Is Glisen PM the same as taking the three drugs separately?<\/h3>\n<p>Clinically, yes &mdash; same molecules at the same doses. The fixed-dose combination improves adherence and typically costs less, but offers less flexibility if one component needs a dose change.<\/p>\n<h3 class=\"wp-block-heading\">Will Glisen PM cause low blood sugar?<\/h3>\n<p>Yes &mdash; it contains glimepiride, a sulfonylurea. Skipping meals, unusual exercise, alcohol without food, and renal impairment all raise hypoglycaemia risk. Always take with food and carry glucose tablets.<\/p>\n<h3 class=\"wp-block-heading\">How much weight will I gain on Glisen PM?<\/h3>\n<p>Typically 2&ndash;4 kg over the first year &mdash; driven by pioglitazone (fluid and fat redistribution) and glimepiride (anabolic effect of more insulin). Metformin partially offsets this. Diet and exercise are the best counterweights.<\/p>\n<h3 class=\"wp-block-heading\">Should I switch to insulin instead?<\/h3>\n<p>That is a decision for you and your prescriber. Insulin gives more predictable glucose control and is essential once beta-cell reserve is exhausted, but it requires injections and has its own hypoglycaemia and weight-gain profile. Triple oral therapy is often tried first in motivated patients who want to avoid injections.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Glisen PM online?<\/h3>\n<p>You can order Glisen PM (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Relaterte diabetesmedikamenter<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nb\/pioglit-mf-forte\/\">Pioglit MF Forte &mdash; Pioglitazone + Metformin dual combo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/glycomet-gp\/\">Glycomet-GP &mdash; Metformin + Glimepiride<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/amaryl\/\">Amaryl &mdash; Glimepiride monotherapy<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/glycomet-sr\/\">Glycomet SR \u2014 Metformin med langsom frigj\u00f8ring<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/januvia\/\">Januvia &mdash; Sitagliptin (DPP-4 inhibitor alternative)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin (SGLT-2-alternativ)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/diabetes-medication\/\"><strong>Se alle diabetesmedikamenter<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Medisinsk ansvarsfraskrivelse.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Triple-drug diabetes therapy carries a cumulative side-effect profile (hypoglycaemia, weight gain, oedema, lactic acidosis) &mdash; always use under close medical supervision.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterte alternativer<\/h3>\n<p>Andre produkter innen <strong>Kroniske tilstander<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nb\/methimez\/\">Methimez<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/betapro-sr\/\">Betapro-SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/biodib-30\/\">Biodib 30<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/brufen\/\">Brufen<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/duovir-n\/\">Duovir N<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Regulerer blodsukker<br \/>\n\u2705 Controls diabetes<br \/>\n\u2705 Forbedrer insulinf\u00f8lsomhet<br \/>\n\u2705 Reduces glucose levels<br \/>\n\u2705 Forbedrer glykemisk kontroll<\/p>\n<p>Glisen PM contains Glimepiride, Metformin, and Pioglitazone.<\/p>","protected":false},"featured_media":57403,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3251,4296,3255,4297],"class_list":{"0":"post-57402","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glimepiride","11":"product_tag-glisen-pm","12":"product_tag-metformin","13":"product_tag-pioglitazone","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/57402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=57402"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/57403"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=57402"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=57402"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=57402"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=57402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}